Advisory Research’s NRC Health Common Stock NRC Stock Holding History

Advisory Research’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,622	Closed	-$210K	–	332
2020 Q1	$210K	Sell	4,622 -13,921	-75%	-$836K	0.01%	270
2019 Q4	$1.22M	Buy	18,543 +4,271	+30%	+$261K	0.06%	163
2019 Q3	$824K	Buy	+14,272	New	+$884K	0.04%	210

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advisory Research's NRC Position: Q2 2020 in Review

Advisory Research sold out of NRC Health Common Stock (NRC) in Q2 2020, closing a stake of 4,622 shares — an estimated $210K sold.

Advisory Research first reported a position in NRC in Q3 2019 and held it in 3 quarters. The position peaked at $1.22M in Q4 2019. 95 funds tracked by Wall St. Rank hold NRC as of Q2 2020.

Advisory Research reported no remaining NRC Health Common Stock position as of Q2 2020 after selling out during the quarter.
Advisory Research sold 4,622 NRC Health Common Stock shares in Q2 2020, an estimated $210K.
Advisory Research first reported a position in NRC Health Common Stock in Q3 2019 and held it in 3 quarters.
Advisory Research's NRC Health Common Stock position peaked at $1.22M in Q4 2019.
95 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2020.

Based on Advisory Research's 13F filing for Q2 2020, filed 13 Aug 2020.